Cancer Screening in the United States During the Second Year of the COVID-19 Pandemic.
Jessica StarPriti BandiRebecca L SiegelXuesong HanAdair K MinihanRobert A SmithAhmedin JemalPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Past-year screening prevalence for breast, cervical, and prostate cancer among age-eligible adults in the United States continued to be lower than prepandemic levels in the second year of the COVID-19 pandemic, reinforcing the importance of return to screening health system outreach and media campaigns. The large increase in stool testing emphasizes the role of home-based screening during health care system disruptions.